Related Experiment Video
Updated: Jul 21, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Limited cutaneous systemic sclerosis: report of one case
1Department of Pediatrics, Veterans General Hospital, 160, Sec. 3, Taichung Harbor Road, Taichung 407, Taiwan.
Acta Paediatrica Taiwanica = Taiwan Er Ke Yi Xue Hui Za Zhi
|September 12, 2001
Summary
This case study details a 5-year-old boy with limited systemic sclerosis in Taiwan, presenting with skin changes and Raynaud's phenomenon. Treatment led to some remission of symptoms.
Area of Science:
- Pediatrics
- Rheumatology
- Dermatology
Background:
- Systemic sclerosis is a rare autoimmune disease affecting connective tissues.
- Limited systemic sclerosis typically involves skin thickening and Raynaud's phenomenon.
Observation:
- A 5-year-old boy in Taiwan presented with facial and digital skin tightening, erythema, telangiectasias, subcutaneous calcification, and Raynaud's phenomenon.
- He had a 2-3 year history of skin changes prior to presentation at age 7.
- Laboratory results indicated positive antinuclear antibody (ANA) and Topoisomerase 1 antibody (anti-Scl-70) titers.
Findings:
- Despite positive serological markers for systemic sclerosis, key organ functions (esophagus, lungs, heart, kidneys) remained normal.
- Treatment with Dipyridamole, D-penicillamine, Colchicine, and Nifedipine resulted in partial remission of scleroderma and Raynaud's phenomenon.
Implications:
- This case highlights the importance of early diagnosis and multidisciplinary management of pediatric systemic sclerosis.
- The findings suggest potential therapeutic benefits of the administered medications in managing pediatric limited systemic sclerosis.
- Further research is warranted to understand the long-term prognosis and optimal treatment strategies for childhood-onset systemic sclerosis.
